New study examines 'real-world' safety and efficacy of GLP-1 agonist and SGLT-2 inhibitor combo when used in elderly patients with suboptimal glycemic control
The College of Family Physicians of Canada (CFPC) is embarking on what the CMAJ is calling "an ambitious evaluation" of the country's family medicine residency—a two-year program that many medical leaders believe is too short.